Healthcare Industry News:  Benign Prostatic Hyperplasia 

Devices Urology

 News Release - May 16, 2007

Lumenis Launches 'The Power of One' for VersaPulse(R) PowerSuite(TM) at American Urology Association 2007 Annual Meeting

New CEO Emphasizes Commitment to intense and focused research and development, resulting in Versatile Platform Technologies built for precision and validated by clinicians

YOKNEAM, Israel, May 16 (HSMN NewsFeed) -- Lumenis® Ltd., a global developer, manufacturer and seller of laser, light-based and radiofrequency devices for surgical, aesthetic, ophthalmic, dental and veterinary applications, announced today a new strategic message for its Urology Business, "The Power of One," to highlight the versatility and comprehensive value of Lumenis' VersaPulse® PowerSuite(TM) holmium laser system, at the American Urology Association's annual meeting this month in Anaheim, California.

Mr. Dov Ofer who joined Lumenis as Chief Executive Officer in April 2007, summarized the impact of recent financial changes: "Due to the substantial investment in our company by leading investors, who recognized Lumenis' tremendous value and potential, we are focused more than ever before on technology and product development for the medical community. We are determined to provide physicians the very best in our state-of-the-art systems, which continue to achieve clinical validation and acclaim based on superior results. We intend to excel in service and support to our customers and to being better than ever before."

"We have strengthened our management team with top talent in the various areas of expertise in our company, and I am pleased to announce that Lloyd Diamond, formerly of LaserScope, will manage Lumenis' Surgical Strategic Business Unit worldwide," stated Mr. Ofer.

"Lumenis' unmatched expertise in holmium laser technology has resulted in products suitable for a wide range of urology applications in various treatments. Industry estimates suggest Endoscopic Procedures to be $100M per annum and climbing at a rate of 34% world-wide," informed Mr. Diamond, who added: "Lumenis' VersaPulse PowerSuite was specifically designed to be a comprehensive clinical solution for Urologists and their patients. AUA attendees will be excited to learn of the broad therapeutic possibilities available with improved outcomes in treatments and better utilization of surgical resources."

Dr. James Lingeman, Clinical Professor of Urology at Indiana University School of Medicine and Director of Research, Methodist Hospital Institute for Kidney Disease, (Indianapolis, Indiana, US) stated, "The VersaPulse PowerSuite is truly a multi-purpose technology for the endoscopic treatment of stones, BPH, tumors and other soft tissue conditions. The high power holmium laser is a versatile tool that every urology department should have, and is an essential tool in my OR."

Expert Physicians to Present in the Lumenis Booth at the AUA

Several thought-leading physicians are scheduled to present based on their own experience using VersaPulse PowerSuite, in the Lumenis booth throughout the AUA. For a complete list of speaker presentations, visit Lumenis booth #1332 at the American Urology Association meeting in The Anaheim Convention Center, May 19-23, 2007. Or for more immediate speaker agenda information, log onto: http://www.GetPowerSuite.com

About 'The Power of One' VersaPulse PowerSuite

The VersaPulse PowerSuite laser system, the first holmium cleared by the FDA for treatment of Benign Prostatic Hyperplasia (BPH), is also effective for surgical removal of kidney stones, bladder tumors and strictures. This one wavelength transforms into many tissue effects to offer a comprehensive solution for physicians and their patients. For more information about 'The Power of One' VersaPulse PowerSuite, log onto: http://www.GetPowerSuite.com

About Lumenis

Lumenis is a global developer, manufacturer and seller of laser, light- based and radiofrequency devices for surgical, aesthetic, ophthalmic, dental and veterinary applications. The Company offers a wide range of products along with extensive product support systems including training, education and service. Lumenis invests heavily in research and development to maintain and enhance its leading industry position. The Company holds numerous patents worldwide on its technologies. For more information about Lumenis and its products, log onto: http://www.lumenis.com.


Source: Lumenis

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.



FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.